Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Keywords

Desogestrel, Medicine, Factor V Leiden, Thrombophilia, Relative risk

References

• Low dose combined oral contraceptivesH. Furniss, Helen W. Sullivan, Cheryl Fitzgerald — 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein CRogier M. Bertina, Bobby P. C. Koeleman, Ted Koster — 1994
• Oral-contraceptive use in relation to myocardial infarction.Samuel Shapiro, Dennis Slone, Lynn Rosenberg — 1979
• Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.Øjvind Lidegaard — 1993
• Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.Jan P. Vandenbroucke, Ted Koster, Frits R. Rosendaal — 1994
• The natural history and epidemiology of venous thrombosis.Cedric J. Carter — 1994
• Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.L. E. Böttiger, G Boman, Gustav Eklund — 1980
• Oral contraceptives and venous thromboembolism: findings in a large prospective study.Martin Vessey, David Mant, Alexandra Smith — 1986
• Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsW.H.W. Inman, Martin Vessey, B Westerholm — 1970
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.Ted Koster, Jan P. Vandenbroucke, FR Rosendaal — 1993
• Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease.B. Burt Gerstman, Joyce M. Piper, Dianne Tomita — 1991
• New progestogens in oral contraception.K. Fotherby, Amy Caldwell — 1994
• EVALUATION OF A NEW GENERATION OF ORAL CONTRACEPTIVESLeon Speroff, Alan H. DeCherney — 1993
• The risk of deep venous thrombosis: a computerized epidemiologic approach.Janssen Hf, J Schachner, Julie C. Hubbard — 1987

Cited by

• Oral Contraception and the Risk of ThromboembolismJames Drife — 2002
• Third generation oral contraception and venous thromboembolismAntonio Cano Mata — 1996
• Third-generation oral contraceptives and thromboembolism risk.Frédéric Gavelle — 1997
• Benefits and risks of oral contraceptives.Luís Miguel Pestana de Vasconcelos — 1999
• Combined oral contraceptives, smoking, and cardiovascular risk.Gregorio Rodríguez Cabrero — 1998
• Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability.M. Adler — 2000
• The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.Emily Youngs — 2001
• Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis.James E. Dalen — 2002
• Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.Francisco Piñaga Otamendi, Maria Jesús Gracia, Jorge Peña — 2003
• Hereditary and Acquired ThrombophiliaЦвык Владимир Анатольевич — 2000
• Hormonal contraception and risk of venous thromboembolism: national follow-up studyJohn Douglas Wigboldus — 2009
• Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.Andrés Juan Recalde Castells — 2010
• Estrogen-Free Oral Hormonal Contraception: Benefits of the Progestin-Only Pill:C.A. Falcone — 2010
• Oral contraceptives and venous thromboembolism. A case-control study.Øjvind Lidegaard, Birgitte Edström, Svend Kreiner — 1998
• Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the UKE. Boretti — 2014
• Combined hormonal contraception and the risk of venous thromboembolism: a guideline.Karolina Solberg, Linda Svensson, Cecilia Sjögren — 2017
• Oral Contraceptives and Venous ThromboembolismLamberto Manzoli, Corrado De Vito, Carolina Marzuillo — 2012
• Activated protein C resistance--a major risk factor for thrombosis.S. Rosén, Augueste Sturk — 1997
• Hormone-induced changes in the coagulation systemS.N. Tchaikovski — 2009
• Effect of Oral Contraceptives on Haemostasis VariablesCornelis Kluft, Mirian Lansink — 1997

Related papers

• Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Emmanuel J. Favaloro — 2019
• The utility of thrombophilia testingMassimo Franchini — 2014
• Inherited and acquired thrombophilia in women of Indian ethnicity with recurrent pregnancy loss: An observational study from North India.Priyanka Mishra, Kanwaljeet Singh, Seema Tyagi — 2021
• Inherited thrombophilia and obstetric complicationsValerio De Stefano, Elena Rossi, Tommaso Zà — 2009
• Treatment for Factor V Leiden, Stuck Between a Rock and a Hard Place: A Case Report and Review of LiteratureWaqas Jehangir, Souad Enakuaa, Victoria Udezi — 2014
• Venous thromboembolism and thrombophilia testingMaeve P. Crowley, Beverley J. Hunt — 2017
• Factor V Leiden and thrombophilia.P Simioni, A Scudeller, A Girolami — 1995
• Venous thromboembolism and thrombophilia testingBeverley J. Hunt — 2013
• Factor V Leiden: A Clinical ReviewNorman M. Kaplan, Biff F. Palmer, Ray Lee — 2001